Related Experiment Video
Updated: Apr 5, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
Jie Zheng1, Frank L van de Veerdonk2, Katherine L Crossland1
1Primary Immune Deficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Abstract:
Signal transducer and activator of transcription 3 (STAT3) triggered production of Th-17 cytokines mediates protective immunity against fungi. Mutations affecting the STAT3/interleukin 17 (IL-17) pathway cause selective susceptibility to fungal (Candida) infections, a hallmark of chronic mucocutaneous candidiasis (CMC). In patients with autosomal dominant CMC, we and others previously reported defective Th17 responses and underlying gain-of-function (GOF) STAT1 mutations, but how this affects STAT3 function leading to decreased IL-17 is unclear. We also assessed how GOF-STAT1 mutations affect STAT3 activation, DNA binding, gene expression, cytokine production, and epigenetic modifications. We excluded impaired STAT3 phosphorylation, nuclear translocation, and sequestration of STAT3 into STAT1/STAT3 heterodimers and confirm significantly reduced transcription of STAT3-inducible genes (RORC/IL-17/IL-22/IL-10/c-Fos/SOCS3/c-Myc) as likely underlying mechanism. STAT binding to the high affinity sis-inducible element was intact but binding to an endogenous STAT3 DNA target was impaired. Reduced STAT3-dependent gene transcription was reversed by inhibiting STAT1 activation with fludarabine or enhancing histone, but not STAT1 or STAT3 acetylation with histone deacetylase (HDAC) inhibitors trichostatin A or ITF2357. Silencing HDAC1, HDAC2, and HDAC3 indicated a role for HDAC1 and 2. Reduced STAT3-dependent gene transcription underlies low Th-17 responses in GOF-STAT1 CMC, which can be reversed by inhibiting acetylation, offering novel targets for future therapies.
Insights
Gain-of-function STAT1 mutations impair Signal transducer and activator of transcription 3 (STAT3) gene transcription, reducing protective Th-17 cytokines in chronic mucocutaneous candidiasis. This defect is reversible via epigenetic modification, suggesting new therapeutic avenues.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Signal transducer and activator of transcription 3 (STAT3) and Th-17 cytokines are crucial for fungal immunity.
- Chronic mucocutaneous candidiasis (CMC) is linked to impaired STAT3/interleukin 17 (IL-17) pathways.
- Gain-of-function (GOF) STAT1 mutations in autosomal dominant CMC cause defective Th17 responses, but their effect on STAT3 is not fully understood.
Purpose of the Study:
- To investigate how GOF-STAT1 mutations impact STAT3 activation, DNA binding, gene expression, and epigenetic modifications.
- To elucidate the mechanism behind decreased IL-17 production in CMC patients with GOF-STAT1 mutations.
Main Methods:
- Assessed STAT3 phosphorylation, nuclear translocation, and STAT1/STAT3 heterodimer formation.
- Analyzed STAT3-inducible gene transcription, STAT DNA binding affinity, and cytokine production.
- Utilized histone deacetylase (HDAC) inhibitors (trichostatin A, ITF2357) and HDAC1/2/3 silencing to evaluate epigenetic modifications.
Main Results:
- Impaired STAT3 phosphorylation, nuclear translocation, or STAT1/STAT3 heterodimerization were ruled out.
- Significantly reduced transcription of STAT3-inducible genes (e.g., RORC, IL-17, IL-22) was observed.
- STAT3 binding to an endogenous DNA target was impaired, while binding to high-affinity elements remained intact.
- Reduced STAT3-dependent gene transcription was reversed by inhibiting STAT1 or enhancing histone acetylation using HDAC inhibitors.
- HDAC1 and HDAC2 were implicated in the observed epigenetic dysregulation.
Conclusions:
- Reduced STAT3-dependent gene transcription is the underlying mechanism for diminished Th-17 responses in GOF-STAT1 CMC.
- Epigenetic modifications, specifically histone acetylation, play a critical role in regulating STAT3 function in this context.
- Targeting epigenetic pathways, particularly HDACs, offers a promising therapeutic strategy for CMC.
More Related Videos
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
09:24Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host
Published on: October 12, 2022
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Gene Regulation in Microbial Communities: Quorum Sensing
The JAK-STAT Signaling Pathway